Ketamine-pancuronium induction in patients with aortic stenosis

Area of Science:

• Cardiovascular Anesthesiology
• Pharmacology
• Cardiac Surgery

Background:

• Severe aortic stenosis poses significant anesthetic challenges.
• Hemodynamic management is critical during induction for patients undergoing aortic valve replacement.
• Understanding drug interactions is vital for patient safety.

Purpose of the Study:

• To compare the cardiovascular effects of two anesthetic induction sequences in patients with severe aortic stenosis.
• To evaluate the interaction between ketamine, diazepam, morphine, and pancuronium on systolic blood pressure.

Main Methods:

• Prospective study involving 15 patients with severe aortic stenosis undergoing aortic valve replacement.
• Administration of ketamine followed by pancuronium in one group.
• Administration of diazepam plus morphine followed by pancuronium in a separate group.
• Monitoring of systolic blood pressure changes during anesthetic induction.

Main Results:

• Ketamine followed by pancuronium resulted in a 25% increase in systolic blood pressure.
• Diazepam plus morphine followed by pancuronium led to a 22% decrease in systolic blood pressure.
• Pancuronium did not block the hypertensive response to ketamine.

Conclusions:

• Ketamine administration causes a significant rise in systolic blood pressure in severe aortic stenosis patients.
• Pancuronium does not antagonize the hypertensive effects of ketamine.
• The combination of diazepam and morphine with pancuronium causes a hypotensive effect.